Canada’s cannabis innovation landscape is experiencing a seismic shift as a new wave of technology startups races to commercialize THCP—a rare cannabinoid reportedly up to 33 times stronger than THC in binding affinity to CB1 receptors. These ventures are positioning the country at the forefront of next-generation cannabis science, merging advanced extraction technologies, precision biotechnology, and artificial intelligence to unlock therapeutic and recreational applications that were previously impossible.
The emergence of THCP-focused startups represents more than incremental product…